Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Alexander van Akkooi MD, PhD, FRACS
Alexander C. J. van Akkooi MD, PhD, FRACS Associate Editor
Sarah Goldberg MD, MPH
Sarah B. Goldberg MD, MPH Advisory Board
Elizabeth Smyth MD
Elizabeth Smyth MD Advisory Board
See All Experts
Published in Oncology

Journal Scan / Research · January 16, 2022

Clonotypic DNA in the Cerebrospinal Fluid as a Marker of CNS Invasion in Lymphoma

Blood Advances

 

 Save  Recommend
 Share

Additional Info

Blood Advances
Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma
Blood Adv 2021 Dec 28;5(24)5525-5535, AJ Olszewski, AD Chorzalska, M Petersen, TA Ollila, A Zayac, H Kurt, DO Treaba, JL Reagan, A Hsu, PC Egan, J Butera, R Niroula, J Vatkevich, J Robison, I Sahin, AP Jacob, CD Mullins, PM Dubielecka

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Brain Cancer Center of Excellence

Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.

Further Reading

Most Read This Week

Recently Updated